Intraepithelial Lymphocytes in Celiac Disease License to Kill Revealed by Sollid, Ludvig M.
Immunity, Vol. 21, 303–304, September, 2004, Copyright 2004 by Cell Press
Preview
adding recombinant IL-15 to the biopsy cultures, andIntraepithelial Lymphocytes
an antibody to IL-15 is able to block the effect of gluten,in Celiac Disease: License suggesting that IL-15 is centrally involved in the upregu-
lation of MIC. MIC serves as a ligand for the activatingto Kill Revealed
NKG2D receptor that signals through the associated
DAP10 adaptor protein. NKG2D is expressed on most
NK cells, CD8 TCR and TCR, but normally not
Infiltration of lymphocytes in the small intestinal epi- on CD4 T cells (Bauer et al., 1999). Whereas Meresse
thelium is a hallmark of active celiac disease. In this et al., but not Hu¨e et al., find that expression of NKG2D
issue of Immunity, two papers uncover mechanisms by IEL is increased in active celiac disease, both papers
controlling the cytolytic potential of these cells and report that IEL can lyse epithelial cells via NKG2D. More-
provide evidence that lymphocyte killing of entero- over, Meresse et al. report that IL-15 arms NKG2D-medi-
cytes is an important part of the celiac disease patho- ated cytolysis by freshly isolated IEL. IL-15 seems to be
a key mediator in these events as stimulation of freshlygenesis.
isolated IEL with IL-15 leads to increased expression
of both NKG2D and DAP10, as well as to increased
phosphorylation of ERK. As demonstrated by MeresseCeliac disease is a prevalent disorder caused by an
et al., ERK and JNK are both kinases involved in theinappropriate immune response to dietary gluten pro-
NKG2D signaling, and their observations suggest thatteins. The lesion, localized in the small intestine, is char-
IL-15 primes the NKG2D signaling pathway. Importantly,acterized by villous atrophy, crypt cell hyperplasia, and
the same authors also find that freshly isolated IEL frominfiltration of inflammatory cells in the lamina propria
active celiac disease patients mediate TCR-independentand in the epithelium. The pathological changes are
lysis through NKG2D without the need for IL-15 prestimu-dependent on gluten consumption, and the disease is
lation. In essence, the two papers make the case thateffectively treated by a life-long gluten exclusion diet.
the villous atrophy of active celiac disease is caused byThe disorder has a very strong HLA association. The
IEL-mediated killing of enterocytes, and that the MIC-presence of the HLA-DQ2 or DQ8 molecules is neces-
NKG2D interaction rendered active by IL-15 exposuresary but not sufficient for disease development, and
is critical for this enterocyte killing.there is evidence for involvement of additional genetic
The papers by the Jabri and Caillat-Zucman groupsfactors. The DQ2 and DQ8 molecules bind and present
along with two other recent papers (Groh et al., 2003;gluten peptides to CD4 T cells of the lamina propria.
Ogasawara et al., 2004) indicate that NGK2D plays aThere exist several distinct gluten peptides that are rec-
key role in immune-mediated diseases. Groh et al. foundognized by CD4 T cells. The great majority of these
that CD4CD28 T cells in peripheral blood and synovial
peptides are only or better recognized after conversion
tissues of rheumatoid arthritis patients express NKG2D
of certain Gln residues to Glu (i.e., deamidation), a pro-
and are able to recognize MIC molecules aberrantly ex-
cess mediated in vivo by the enzyme tissue transglutam- pressed on synoviocytes of affected joints. Ogasawara
inase. The key genetic role of HLA suggests that the DQ et al. found that autoreactive CD8 T cells infiltrating
restricted T cells play a critical position in shaping the pancreas islets of NOD mice express NKG2D, and that
anti-gluten response leading to celiac disease (Sollid, NKG2D blockade prevents autoimmune diabetes. Thus,
2002). while NKG2D may exert beneficial functions during in-
The increased number of intraepithelial lymphocytes fections and against tumor cells, it may also serve as
(IEL) is typical of active celiac disease. The majority of an immune activator that can tip the balance in favor of
these cells are TCR CD8CD4 and a significant autoimmunity and chronic inflammation. The observa-
proportion are TCR CD8CD4. IEL express a variety tion by Meresse et al. that NKG2D can mediate cytolysis
of NK lineage receptors (Jabri et al., 2000; Roberts et independent of TCR ligation in recently activated T cells
al., 2001). It has previously been demonstrated that IEL is particularly relevant in this context. Their observation
have a cytolytic potential (Lundqvist et al., 1996; Ober- suggests that self-perpetuating loops of immune activa-
huber et al., 1996), but until now it has been unknown tion can be established. With regard to the situation in
what controls their cytotoxicity. The papers by Meresse celiac disease, it still remains to be determined which
et al. and Hu¨e et al. bring interesting new knowledge on antigenic stimulus is responsible for the recent in vivo
the function of IEL in celiac disease and shed light on activation of the intraepithelial T cells that seems to be
the role of NK lineage receptors in immune-mediated required for TCR-independent lysis, and whether this
disorders. The papers demonstrate that the enterocyte antigen stimulation is unique to celiac disease patients.
expression of the nonconventional HLA molecule MIC Another issue not fully explained by the findings of
is upregulated in active celiac disease. MIC molecules work by the Jabri and Caillat-Zucman groups is how
are known to be induced in enterocytes by stress (Groh the IEL cytotoxicity relates to HLA-DQ2/DQ8, whose
et al., 1996), and Hu¨e et al. demonstrate that the expres- presence is mandatory for celiac disease development.
sion of MIC by enterocytes is increased in intestinal The gluten peptide (gliadin p31-49), which was the most
biopsies cultured in vitro with gluten or certain gluten active in inducing MIC in the Hu¨e et al. study, does
not appear to be recognized by DQ restricted, gluten-peptides. The same MIC-inducing effect is observed by
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304
reactive T cells of the gut (Arentz-Hansen et al., 2000). University of Oslo
N-0027 OsloA length variant of the same peptide (gliadin p31-43)
Norwayhas previously been found to induce innate immune
activation in intestinal biopsies of celiac disease pa-
Selected Readingtients cultured in vitro with gluten (Maiuri et al., 2003).
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